A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2011
12/01/2011	US20110293587 Glucagon analogues
12/01/2011	US20110293586 Glucagon analogues
12/01/2011	US20110293585 Compositions and methods for treatment of lysosomal storage disorders
12/01/2011	US20110293567 Use of bacteria for the sensing and killing of cancer cells
12/01/2011	CA2799596A1 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra
12/01/2011	CA2799207A1 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
11/2011
11/30/2011	EP2390331A1 MicroRNA molecules
11/30/2011	EP2390330A1 MicroRNA molecules
11/30/2011	EP2390329A1 MicroRNA molecules
11/30/2011	EP2390328A1 MicroRNA molecules
11/30/2011	EP2390312A1 Methods of improving stem cell homing and engraftment
11/30/2011	EP2389158A1 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
11/30/2011	EP1545565B1 Compositions comprising mitotically inactivated allogenic fibroblasts and keratinocytes for use in tissue regeneration
11/30/2011	EP1409025B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies
11/30/2011	CN1656222B 反义iap核碱基寡聚物及其应用 Iap nucleobase antisense oligomer and its application
11/30/2011	CN102264898A 微小rna的功能抑制方法 Small rna function Suppression
11/30/2011	CN102260712A 溶肿瘤能力增强的B型人腺病毒Ad11突变体的构建和应用 Soluble tumor capacity enhancement of B-type human adenovirus Ad11 mutant constructs and applications
11/30/2011	CN102260701A 一种鸡防御素9基因表达载体及其制备方法和应用 One kind of chicken 9 defensin gene expression vector and its preparation method and application
11/30/2011	CN102260698A 大肠杆菌中表达PTA-linker-thanatin融合蛋白及其抗癌研究 PTA-linker-thanatin fusion proteins expressed in E. coli and cancer research
11/30/2011	CN102260673A 靶向人血管紧张素原的rna干扰片段、表达载体与应用 Targeting human angiotensinogen rna interference fragment expression vector and application
11/30/2011	CN102260672A 抑制猪生长抑素受体2基因表达的siRNA Pigs suppression of gene expression of somatostatin receptor 2 siRNA
11/30/2011	CN102260667A 细胞微粒子-siRNA复合物的制备及其在艾滋病治疗中的应用 Preparation of cell particles -siRNA complex and its application in the treatment of AIDS
11/30/2011	CN102260376A 一种用作非病毒型基因载体的新型阳离子聚合物及其制备方法和用途 For use as a non-viral gene vectors novel cationic polymers and their preparation and use
11/30/2011	CN102260356A 一种用作基因载体的壳聚糖衍生物及其制备方法和用途 For use as a gene carrier chitosan derivative and its preparation method and use
11/30/2011	CN102260322A 幽门螺杆菌抗原肽及其应用 Helicobacter pylori antigen peptide and its application
11/30/2011	CN102258792A 质粒pUDK-SPK1在预防或治疗组织粘连中的应用 Plasmid pUDK-SPK1 application in the prevention or treatment of tissue adhesion
11/30/2011	CN102258779A 四种及四种以上hiv载体基因疫苗序贯及重复应用 Four kinds of hiv carriers and more than four sequential and repeated applications of gene vaccine
11/30/2011	CN102258778A 生物分子表面展示及其用途 Biomolecular surface display and uses
11/30/2011	CN101818171B 人ski基因真核表达载体、制备方法及其应用 People ski eukaryotic expression vector, preparation method and application
11/30/2011	CN101805750B 法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途 Farnesyl pyrophosphate synthase rna interference lentiviral vector and uses
11/30/2011	CN101735418B 生物可降解阳离子聚合物及其应用 Biodegradable cationic polymer and its application
11/30/2011	CN101649319B 肿瘤特异嵌合启动子及其构建方法和应用 Tumor-specific chimeric promoter and its construction method and application
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067567 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
11/29/2011	US8067545 Isolated antibodies against biologically active leptin-related peptides
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067387 Method for stimulating angiogenesis using DKK2 and composition comprising the same
11/29/2011	US8067386 Modulation of eIF4E-BP2 expression
11/29/2011	US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011	US8067363 Compositions and methods for promoting lipid mobilization in humans
11/29/2011	US8067240 Methods for the diagnosis and treatment of lung cancer
11/29/2011	US8067229 Ucp4
11/29/2011	US8067227 Viral vectors and the use of the same for gene therapy
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
11/29/2011	US8067156 From adeno-associated virus; for treatment of acute conditions requiring rapid gene expression
11/29/2011	US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011	US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8066982 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing and treating HIV
11/29/2011	US8066972 Altering memory by affecting staufen function
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2478645C Treatment of central nervous system damage
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2366541C Novel recombinant and mutant herpesviruses
11/29/2011	CA2346931C Gene delivery system and methods of use
11/24/2011	WO2011146879A2 Methods and compositions related to modulating autophagy
11/24/2011	WO2011146788A2 Methods of assessing a risk of developing necrotizing meningoencephalitis
11/24/2011	WO2011146100A1 Breast cancer therapy using an engineered respiratory syncytial virus
11/24/2011	WO2011145745A1 Vesicles with encapsulated substance and production method therefor
11/24/2011	WO2011144358A1 Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
11/24/2011	WO2011050000A3 Single molecule nucleic acid nanoparticles
11/24/2011	WO2010118213A3 Particles for delivery of nucleic acids and related devices and methods
11/24/2011	US20110289611 Rna sequence-specific mediators of rna interference
11/24/2011	US20110288160 Treatment of Metabolic-Related Disorders Using Hypothalamic Gene Transfer of BDNF and Compositions Therefor
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288002 Novel bag proteins and nucleic acid molecules encoding them
11/24/2011	US20110287950 Protein fragment complementation assays for the detection of biological or drug interactions
11/24/2011	US20110287513 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287086 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered in Vivo
11/24/2011	US20110287084 Method for reducing body fat and increasing lean body mass by reducing stearoyl-coa desaturase 1 activity
11/24/2011	US20110287058 Universal GM-CSF Expressing Bystander Human Cell Line
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287004 Mg53 compositions and methods of use
11/24/2011	US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/24/2011	US20110286983 Long lasting drug formulations
11/24/2011	US20110286982 Glucagon analogues
11/24/2011	US20110286981 Glucagon analogues
11/24/2011	US20110286972 Virus growing in hypoxic cell or virus vector expressing gene therein
11/24/2011	US20110286937 Synthetic glycolipid-containing liposome
11/24/2011	US20110286933 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
11/23/2011	EP2388318A1 Antisense modulation of connective tissue growth factor expression
11/23/2011	EP2388317A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/23/2011	EP2388015A1 DNA expression vectors and methods of use
11/23/2011	EP2387999A1 Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
11/23/2011	EP1817411B1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/23/2011	CN102257138A Tumor antigen peptide and use thereof
11/23/2011	CN102257002A Truncated cd20 protein, deltacd20
11/23/2011	CN102256606A Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
11/23/2011	CN102251037A Application of miRNA-23a antisense nucleotide in preparation of medicine for treating heart diseases
11/23/2011	CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof
11/23/2011	CN102250916A Brown croaker chemotactic factor CC gene, and detection method and application thereof
11/23/2011	CN102250915A Miichthys miiuy alpha chemokine gene CXCL10 as well as detection method and application thereof
11/23/2011	CN102250904A Medicine for preventing and/or treating melanoma

1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 870